Research ExplorerJournalsBLOOD CANCER J

BLOOD CANCER J - Blood Cancer Journal

Bibliographical data

ISSNs2044-5385
Electronic ISSN 2044-5385

Publications

PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation
Penack, O., Abouqateb, M., Peczynski, C., Boreland, W., Gülbas, Z., Gedde-Dahl, T., Castilla-Llorente, C., Kröger, N., Eder, M., Rambaldi, A., Bonifazi, F., Blau, I. W., Stelljes, M., Dreger, P., Moiseev, I., Schoemans, H., Koenecke, C. & Peric, Z., 15.03.2024, In: BLOOD CANCER J. 14, 1, p. 45

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma
Mai, E. K., Huhn, S., Miah, K., Poos, A. M., Scheid, C., Weisel, K. C., Bertsch, U., Munder, M., Berlanga, O., Hose, D., Seckinger, A., Jauch, A., Blau, I. W., Hänel, M., Salwender, H. J., Benner, A., Raab, M. S., Goldschmidt, H. & Weinhold, N., 04.01.2023, In: BLOOD CANCER J. 13, 1, p. 1

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT
Raj, K., Eikema, D-J., Sheth, V., Koster, L., de Wreede, L. C., Blaise, D., Di Grazia, C., Koc, Y., Potter, V., Chevallier, P., Lopez-Corral, L., Wu, D., Mielke, S., Maertens, J., Meijer, E., Huynh, A., Passweg, J., Luft, T., Pérez-Simón, J. A., Ciceri, F., Piekarska, A., Hayri Ozsan, G., Kröger, N., Robin, M. & Yakoub-Agha, I., 28.09.2022, In: BLOOD CANCER J. 12, 9, p. 140

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia
Pratz, K. W., Panayiotidis, P., Recher, C., Wei, X., Jonas, B. A., Montesinos, P., Ivanov, V., Schuh, A. C., DiNardo, C. D., Novak, J., Pejsa, V., Stevens, D., Yeh, S-P., Kim, I., Turgut, M., Fracchiolla, N., Yamamoto, K., Ofran, Y., Wei, A. H., Bui, C. N., Benjamin, K., Kamalakar, R., Potluri, J., Mendes, W., Devine, J. & Fiedler, W., 20.04.2022, In: BLOOD CANCER J. 12, 4, 71.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Author Correction: 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy
Wei, A. H., Panayiotidis, P., Montesinos, P., Laribi, K., Ivanov, V., Kim, I., Novak, J., Stevens, D. A., Fiedler, W., Pagoni, M., Bergeron, J., Ting, S. B., Hou, J-Z., Anagnostopoulos, A., McDonald, A., Murthy, V., Yamauchi, T., Wang, J., Chyla, B., Sun, Y., Jiang, Q., Mendes, W., Hayslip, J. & DiNardo, C. D., 26.10.2021, In: BLOOD CANCER J. 11, 10, p. 171

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy (141/150)
Wei, A. H., Panayiotidis, P., Montesinos, P., Laribi, K., Ivanov, V., Kim, I., Novak, J., Stevens, D. A., Fiedler, W., Pagoni, M., Bergeron, J., Ting, S. B., Hou, J-Z., Anagnostopoulos, A., McDonald, A., Murthy, V., Yamauchi, T., Wang, J., Chyla, B., Sun, Y., Jiang, Q., Mendes, W., Hayslip, J. & DiNardo, C. D., 01.10.2021, In: BLOOD CANCER J. 11, 10, p. 163

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life
Terpos, E., Mikhael, J., Hajek, R., Chari, A., Zweegman, S., Lee, H. C., Mateos, M-V., Larocca, A., Ramasamy, K., Kaiser, M., Cook, G., Weisel, K. C., Costello, C. L., Elliott, J., Palumbo, A. & Usmani, S. Z., 18.02.2021, In: BLOOD CANCER J. 11, 2, p. 40

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma
Baertsch, M-A., Mai, E. K., Hielscher, T., Bertsch, U., Salwender, H. J., Munder, M., Fuhrmann, S., Dührsen, U., Brossart, P., Neben, K., Schlenzka, J., Kunz, C., Raab, M. S., Hillengaß, J., Jauch, A., Seckinger, A., Hose, D., Luntz, S., Sonneveld, P., Lokhorst, H., Martin, H., Goerner, M., Hoffmann, M., Lindemann, H-W., Bernhard, H., Blau, I. W., Scheid, C., Besemer, B., Weisel, K. C., Hänel, M., Dürig, J., Goldschmidt, H. & German-speaking Myeloma Multicenter Group (GMMG), 07.01.2021, In: BLOOD CANCER J. 11, 1, p. 1

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study
Dimopoulos, M. A., Lonial, S., White, D., Moreau, P., Weisel, K., San-Miguel, J., Shpilberg, O., Grosicki, S., Špička, I., Walter-Croneck, A., Magen, H., Mateos, M-V., Belch, A., Reece, D., Beksac, M., Spencer, A., Oakervee, H., Orlowski, R. Z., Taniwaki, M., Röllig, C., Einsele, H., Matsumoto, M., Wu, K. L., Anderson, K. C., Jou, Y-M., Ganetsky, A., Singhal, A. K. & Richardson, P. G., 04.09.2020, In: BLOOD CANCER J. 10, 9, p. 91

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis
Dimopoulos, M. A., Niesvizky, R., Weisel, K., Siegel, D. S., Hajek, R., Mateos, M-V., Cavo, M., Huang, M., Zahlten-Kumeli, A. & Moreau, P., 09.03.2020, In: BLOOD CANCER J. 10, 3, p. 35

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (31)